IMCR Dividend: Immunocore Holdings PLC Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

IMCR Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	379	310	249	143	26	30
Revenue Growth (YoY)	-20%	25%	74%	450%	-13%	20%
Cost of Revenue	2	2	1	0	--	--
Gross Profit	376	307	248	143	--	--
Selling, General & Admin	165	155	144	90	74	45
Research & Development	256	222	163	89	73	74
Operating Expenses	421	377	308	184	154	120
Other Non Operating Income (Expenses)	16	14	0	-5	-4	0
Pretax Income	-28	-52	-60	-44	-140	-87
Income Tax Expense	1	-1	-5	-2	-9	-13
Net Income	-29	-51	-55	-41	-131	-74
Net Income Growth	-65%	-7%	34%	-69%	77%	-28%
Shares Outstanding (Diluted)	50.4	49.99	48.88	45.7	42.5	42.3
Shares Change (YoY)	-5%	2%	7%	8%	0%	0%
EPS (Diluted)	-0.58	-1.02	-1.13	-0.9	-3.1	-1.75
EPS Growth	-62%	-10%	26%	-71%	77%	-28.99%
Free Cash Flow	2	20	-2	-28	-97	-64
Free Cash Flow Per Share	0.03	0.4	-0.04	-0.61	-2.28	-1.51
Gross Margin	99.2%	99.03%	99.59%	100%	--	--
Operating Margin	-11.87%	-22.58%	-23.69%	-28.67%	-492.3%	-296.66%
Profit Margin	-7.65%	-16.45%	-22.08%	-28.67%	-503.84%	-246.66%
Free Cash Flow Margin	0.52%	6.45%	-0.8%	-19.58%	-373.07%	-213.33%
EBITDA	-42	-66	-55	-37	-121	-81
EBITDA Margin	-11.08%	-21.29%	-22.08%	-25.87%	-465.38%	-270%
D&A For EBITDA	3	4	4	4	7	8
EBIT	-45	-70	-59	-41	-128	-89
EBIT Margin	-11.87%	-22.58%	-23.69%	-28.67%	-492.3%	-296.66%
Effective Tax Rate	-3.57%	1.92%	8.33%	4.54%	6.42%	14.94%